ASTRAZENECA PHARMA INDIA
Back to Income Statement
|
ASTRAZENECA PHARMA INDIA Last 5 Year Revenue History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹1,716 Cr | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr | ₹814 Cr |
What is the latest Revenue of ASTRAZENECA PHARMA INDIA ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹1,716 Cr |
| Mar2024 | ₹1,296 Cr |
| Mar2023 | ₹1,003 Cr |
| Mar2022 | ₹806 Cr |
| Mar2021 | ₹814 Cr |
How is Revenue of ASTRAZENECA PHARMA INDIA Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,716 Cr | 32.48 | |
| Mar2024 | ₹1,296 Cr | 29.17 | |
| Mar2023 | ₹1,003 Cr | 24.50 | |
| Mar2022 | ₹806 Cr | -0.98 | |
| Mar2021 | ₹814 Cr | - | |
Compare Revenue of peers of ASTRAZENECA PHARMA INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASTRAZENECA PHARMA INDIA | ₹21,797.6 Cr | -3% | 6.1% | 10.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,469.0 Cr | -2.8% | -1% | 6.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,305.0 Cr | -3.3% | 0.4% | -2.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,014.0 Cr | -3.1% | 2.9% | 36.9% | Stock Analytics | |
| CIPLA | ₹111,388.0 Cr | -2.7% | 5.3% | -6.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,381.0 Cr | -4.1% | -3.7% | 3.7% | Stock Analytics | |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASTRAZENECA PHARMA INDIA | -3% |
6.1% |
10.3% |
| SENSEX | -2.4% |
-3.7% |
-9.2% |
You may also like the below Video Courses